
Sign up to save your podcasts
Or


Most prosthetic users still manage comfort with socks, a system that’s decades old. Vessl Prosthetics, led by CEO Sydney Robinson, is tackling the biggest pain point in lower-limb prosthetics: poor fit.
From automatic adjustment technology to a clear reimbursement path, Sydney shares how Vessl is positioned to dominate a half-billion-dollar market.
Episode breakdown:
0:00 – Why Sydney Chose Prosthetics
0:38 – Back From LSI & Discovering Sydney’s Pitch
1:15 – Meet Sydney Robinson & Vessl Prosthetics
2:12 – Sydney’s Background & Path to Prosthetics
3:48 – The Big Problem in Prosthetic Fit
5:11 – The Sock Analogy & Comfort Issues
6:18 – Why It’s Called Vessl
7:37 – Product Walkthrough & How It Works
11:44 – Business Model & Market Opportunity
12:39 – Why Vessl Can Dominate the Market
13:52 – Pricing, Reimbursement & Competitive Edge
17:22 – Overcoming “Not Sexy” Industry Perception
19:18 – US Amputee Stats & Global Growth
21:16 – Regulatory Pathway & Launch Timeline
21:55 – Beachhead Market & Early Adopters
23:25 – B2B Model With Consumer Influence
25:40 – Handling Direct Patient Interest
27:38 – Who Is Not a Fit for Vessl
28:49 – What Sydney Would Do With $100M
30:06 – Direct-to-Consumer Possibilities
34:32 – Industry Consolidation & Exits
36:30 – Key Industry Players
37:58 – Why the Product Resonates With Patients
38:41 – Upcoming Conferences & Events
39:25 – Closing & Call to Action
This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.
Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to GrowMyMedtech.com to book time for a free analysis.
Subscribe to our Youtube Channel
https://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfg
Subscribe to our LinkedIn Newsletter
https://www.stateofmedtechpodcast.com/
Follow The State of MedTech on
LinkedIn https://www.linkedin.com/company/thestateofmedtech
Instagram https://www.instagram.com/stateofmedtech/
TikTok https://www.tiktok.com/@stateofmedtech
X https://twitter.com/StateofMedTech
Facebook https://www.facebook.com/stateofmedtech/
Follow Omar M. Khateeb on
LinkedIn https://www.linkedin.com/in/okhateeb/
Instagram https://www.instagram.com/omar.m.khateeb/
TikTok https://www.tiktok.com/@omarkhateebofficial
X https://twitter.com/OmarMKhateeb
Facebook https://www.facebook.com/OmarMKhateeb/
#MedtechLeadership #Prosthetics #HealthcareBusiness #CEOInsights #PatientCare
By State of MedtechMost prosthetic users still manage comfort with socks, a system that’s decades old. Vessl Prosthetics, led by CEO Sydney Robinson, is tackling the biggest pain point in lower-limb prosthetics: poor fit.
From automatic adjustment technology to a clear reimbursement path, Sydney shares how Vessl is positioned to dominate a half-billion-dollar market.
Episode breakdown:
0:00 – Why Sydney Chose Prosthetics
0:38 – Back From LSI & Discovering Sydney’s Pitch
1:15 – Meet Sydney Robinson & Vessl Prosthetics
2:12 – Sydney’s Background & Path to Prosthetics
3:48 – The Big Problem in Prosthetic Fit
5:11 – The Sock Analogy & Comfort Issues
6:18 – Why It’s Called Vessl
7:37 – Product Walkthrough & How It Works
11:44 – Business Model & Market Opportunity
12:39 – Why Vessl Can Dominate the Market
13:52 – Pricing, Reimbursement & Competitive Edge
17:22 – Overcoming “Not Sexy” Industry Perception
19:18 – US Amputee Stats & Global Growth
21:16 – Regulatory Pathway & Launch Timeline
21:55 – Beachhead Market & Early Adopters
23:25 – B2B Model With Consumer Influence
25:40 – Handling Direct Patient Interest
27:38 – Who Is Not a Fit for Vessl
28:49 – What Sydney Would Do With $100M
30:06 – Direct-to-Consumer Possibilities
34:32 – Industry Consolidation & Exits
36:30 – Key Industry Players
37:58 – Why the Product Resonates With Patients
38:41 – Upcoming Conferences & Events
39:25 – Closing & Call to Action
This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.
Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to GrowMyMedtech.com to book time for a free analysis.
Subscribe to our Youtube Channel
https://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfg
Subscribe to our LinkedIn Newsletter
https://www.stateofmedtechpodcast.com/
Follow The State of MedTech on
LinkedIn https://www.linkedin.com/company/thestateofmedtech
Instagram https://www.instagram.com/stateofmedtech/
TikTok https://www.tiktok.com/@stateofmedtech
X https://twitter.com/StateofMedTech
Facebook https://www.facebook.com/stateofmedtech/
Follow Omar M. Khateeb on
LinkedIn https://www.linkedin.com/in/okhateeb/
Instagram https://www.instagram.com/omar.m.khateeb/
TikTok https://www.tiktok.com/@omarkhateebofficial
X https://twitter.com/OmarMKhateeb
Facebook https://www.facebook.com/OmarMKhateeb/
#MedtechLeadership #Prosthetics #HealthcareBusiness #CEOInsights #PatientCare